Related Experiment Video
Updated: Aug 23, 2026

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Silencing the formylpeptide receptor FPR by short-interfering RNA
Yingying Le1, Pablo Iribarren, Ye Zhou
1Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560, Room 31-40, MD 21702-1201, USA.
Abstract:
A double-stranded short-interfering RNA (siRNA) was designed to attenuate the expression and function of the formylpeptide receptor FPR, a G protein-coupled receptor mediating migration and activation of phagocytic leukocytes in response to bacterial chemotactic formylpeptides. Retrovirus-based constructs were generated to introduce FPR-siRNA into a rat leukemia cell line transfected to overexpress FPR. Cells infected with FPR-siRNAT28, which targets the nucleotides 926 to 944 of FPR mRNA corresponding to the third extracellular loop of the putative receptor protein, showed significantly reduced expression of FPR mRNA and protein, in association with impaired calcium mobilization and chemotactic responses to peptide agonists. Direct transduction of synthetic FPR-siRNAT28 into human macrophages also inhibited the expression of FPR and abrogated cell chemotaxis and the release of superoxide anions induced by the bacterial formylpeptide. FPR-siRNA additionally abrogated the expression and function of FPR in a human malignant glioma cell line. Our study demonstrates successful application of siRNA to silence a G protein-coupled chemoattractant receptor involved in inflammation and suggests the potential to use this approach in studies of receptor regulation and prevention of undesirable side effects associated with FPR activation.
Insights
Short-interfering RNA (siRNA) effectively silenced the formylpeptide receptor (FPR) in cell lines. This inhibition reduced leukocyte migration and activation, demonstrating siRNA
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- The formylpeptide receptor (FPR) is a G protein-coupled receptor crucial for phagocytic leukocyte migration and activation.
- Bacterial chemotactic formylpeptides activate FPR, playing a role in inflammatory responses.
Purpose of the Study:
- To design and validate short-interfering RNA (siRNA) targeting FPR expression and function.
- To investigate the potential of siRNA as a tool for regulating FPR activity in cellular models.
Main Methods:
- Development of retrovirus-based constructs for FPR-siRNA delivery into rat leukemia cells overexpressing FPR.
- Transduction of synthetic FPR-siRNA into human macrophages and a human malignant glioma cell line.
- Assessment of FPR mRNA and protein levels, calcium mobilization, chemotaxis, and superoxide anion release.
Main Results:
- FPR-siRNA significantly reduced FPR mRNA and protein expression in transfected rat leukemia cells.
- Inhibition of FPR led to impaired calcium mobilization and chemotactic responses to formylpeptides.
- Direct FPR-siRNA transduction in human macrophages and glioma cells abrogated FPR expression and function, including chemotaxis and superoxide anion release.
Conclusions:
- Successful application of siRNA to silence the G protein-coupled chemoattractant receptor FPR.
- Demonstrates the potential of siRNA technology for studying receptor regulation and mitigating FPR-mediated inflammatory effects.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis
Small interfering RNAs (siRNA)
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

